Atypical uses of atypical antipsychotics

被引:11
作者
Brooke, NS
Wiersgalla, M
Salzman, C
机构
[1] Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA
[5] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
关键词
antipsychotic agents; anxiety disorders; developmental disorders; eating disorders; mood disorders; review;
D O I
10.1080/10673220500433148
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Atypical antipsychotic drugs are primarily indicated for the treatment of psychotic disorders such as schizophrenia and schizoaffective disorder. Recently, they have also been used for mood stabilization. This article reviews other, potentially therapeutically useful indications for these medications. In most cases, the evidence supporting these new uses is limited but provocative, and involves only case reports. it has not yet been determined whether the usefulness of atypical antipsychotics for nonpsychotic disorders outweighs their potential to cause serious side effects.
引用
收藏
页码:317 / 339
页数:23
相关论文
共 118 条
[1]   LSD-like panic from risperidone in post-LSD visual disorder [J].
Abraham, HD ;
Mamen, A .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (03) :238-241
[2]   A case report of risperidone-induced obsessive-compulsive symptoms [J].
Alzaid, K ;
Jones, BD .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) :58-59
[3]   Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence [J].
Aman, MG ;
De Smedt, G ;
Derivan, A ;
Lyons, B ;
Findling, RL .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (08) :1337-1346
[4]   Risperidone may worsen fluoxetine-treated OCD [J].
Andrade, C .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (05) :255-256
[5]   Olanzapine augmentation for trichotillomania [J].
Ashton, AK .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (11) :1929-1930
[6]   Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study [J].
Atmaca, M ;
Kuloglu, M ;
Tezcan, E ;
Gecici, O .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 (03) :115-119
[7]   Risperidone for severe tardive dyskinesia: A 12-week randomized, double-blind, placebo-controlled study [J].
Bai, YM ;
Yu, SC ;
Lin, CC .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) :1342-1348
[8]   Efficacy of olanzapine in social anxiety disorder: a pilot study [J].
Barnett, SD ;
Kramer, ML ;
Casat, CD ;
Connor, KM ;
Davidson, JRT .
JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (04) :365-368
[9]   Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports [J].
Boachie, A ;
Goldfield, GS ;
Spettigue, W .
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2003, 33 (01) :98-103
[10]   Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial [J].
Bogetto, F ;
Bellino, S ;
Vaschetto, P ;
Ziero, S .
PSYCHIATRY RESEARCH, 2000, 96 (02) :91-98